NeuImmune, Inc.
Biotechnology company · Sykesville, Maryland, United States
NeuImmune, Inc. is a biotechnology company headquartered in Sykesville, Maryland, United States. Its earliest recorded incorporation is in 2020. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $574,441 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $20,000 sold in a notice filed in 2021.
NeuImmune at a glance
What does NeuImmune do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $574,441 in total (2022 to 2023). NIH funding came from the National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $20,000 sold (2021).
Frequently asked questions about NeuImmune
Where is NeuImmune headquartered?
NeuImmune, Inc. is headquartered in Sykesville, Maryland, United States.
What does NeuImmune do?
NeuImmune, Inc. is a biotechnology company.
When was NeuImmune founded?
The earliest incorporation on record for NeuImmune, Inc. is in 2020, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences